Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

395 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The influence of comorbidities on achieving an N-terminal pro-b-type natriuretic peptide target: a secondary analysis of the GUIDE-IT trial.
Ezekowitz JA, Alemayehu W, Rathwell S, Grant AD, Fiuzat M, Whellan DJ, Ahmad T, Adams K, Piña IL, Cooper LS, Januzzi JL, Leifer ES, Mark D, O'Connor CM, Felker GM. Ezekowitz JA, et al. Among authors: pina il. ESC Heart Fail. 2022 Feb;9(1):77-86. doi: 10.1002/ehf2.13692. Epub 2021 Nov 16. ESC Heart Fail. 2022. PMID: 34784657 Free PMC article.
Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial.
Cuffe MS, Califf RM, Adams KF Jr, Benza R, Bourge R, Colucci WS, Massie BM, O'Connor CM, Pina I, Quigg R, Silver MA, Gheorghiade M; Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Investigators. Cuffe MS, et al. JAMA. 2002 Mar 27;287(12):1541-7. doi: 10.1001/jama.287.12.1541. JAMA. 2002. PMID: 11911756 Clinical Trial.
Nuggets, pearls, and vignettes of master heart failure clinicians. Part 4--treatment.
Leier CV, Silver MA, Rich MW, Eichhorn EJ, Fowler MB, Giles TD, Johnstone DE, Le Jemtel TH, Lachmann JS, Levine TB, Armstrong PW, Dec WG, Jessup M, Howlett J, Hershberger RE, Cohn JN, Adams KF Jr, Colucci WS, Warner-Stevenson L, Hosenpud JD, Bristow MR, Pina I, Baughman KL, Binkley PF, Ventura HO, Francis GS, White M, Miller LW, Berry B, Missov E. Leier CV, et al. Congest Heart Fail. 2002 Mar-Apr;8(2):98-124. doi: 10.1111/j.1527-5299.2002.01169.x. Congest Heart Fail. 2002. PMID: 11927786 Free article. No abstract available.
Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study.
Klein L, O'Connor CM, Leimberger JD, Gattis-Stough W, Piña IL, Felker GM, Adams KF Jr, Califf RM, Gheorghiade M; OPTIME-CHF Investigators. Klein L, et al. Among authors: pina il. Circulation. 2005 May 17;111(19):2454-60. doi: 10.1161/01.CIR.0000165065.82609.3D. Epub 2005 May 2. Circulation. 2005. PMID: 15867182 Clinical Trial.
Heart failure and a controlled trial investigating outcomes of exercise training (HF-ACTION): design and rationale.
Whellan DJ, O'Connor CM, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ, Leifer ES, Kraus WE, Kitzman DW, Blumenthal JA, Rendall DS, Houston-Miller N, Fleg JL, Schulman KA, Piña IL; HF-ACTION Trial Investigators. Whellan DJ, et al. Among authors: pina il. Am Heart J. 2007 Feb;153(2):201-11. doi: 10.1016/j.ahj.2006.11.007. Am Heart J. 2007. PMID: 17239677 Clinical Trial.
Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial.
Gheorghiade M, Rossi JS, Cotts W, Shin DD, Hellkamp AS, Piña IL, Fonarow GC, DeMarco T, Pauly DF, Rogers J, DiSalvo TG, Butler J, Hare JM, Francis GS, Stough WG, O'Connor CM. Gheorghiade M, et al. Among authors: pina il. Arch Intern Med. 2007 Oct 8;167(18):1998-2005. doi: 10.1001/archinte.167.18.1998. Arch Intern Med. 2007. PMID: 17923601 Clinical Trial.
395 results